Measures to address medical inflation could soften revenue, but issues have abated significantly: IHH Healthcare
CEO says group is now negotiating directly with insurers, offering more packages and discounts
[SINGAPORE] IHH Healthcare will likely face “some softening” in patient admissions and revenue from the measures the group has implemented to combat medical inflation in Malaysia, but the situation has “improved considerably”, said its group chief executive Prem Nair on Friday (May 30).
The group is now negotiating directly with insurers, offering more packages and discounts, he said. Issues that triggered the medical inflation issue, such as a weak ringgit, have “abated significantly”.
“(Medical inflation) has not fully gone away, but we have all now come to the table,” said Dr Nair, noting that the group is also in discussions about medical inflation with parties such as Malaysia’s health ministry and life insurance association.
TRENDING NOW
Qatari LNG ship struck in Strait of Hormuz, testing US talks
DBS, OCBC and UOB shares hit all-time highs as sentiment improves
‘Baptism of fire’: Andre Khor on leading Singapore refiner Aster through an energy crisis
Singapore retains top spot as most expensive city for HNWIs, with five Apac cities in global top 10